When was NeuroLex Diagnostics founded?

NeuroLex Diagnostics was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is NeuroLex Diagnostics located?

NeuroLex Diagnostics is headquartered in Atlanta, United States.

Who is the current CEO of NeuroLex Diagnostics?

Jim Schwoebel of NeuroLex Diagnostics.

How many employees does NeuroLex Diagnostics have?

As of Apr 30, 2026, the latest employee count at NeuroLex Diagnostics is 2.

Is NeuroLex Diagnostics a funded company?

NeuroLex Diagnostics is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jun 2017.

When was the latest funding round of NeuroLex Diagnostics?

NeuroLex Diagnostics' latest funding was a $***** Seed round on Jun 2017, with participation from 0 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $3.25B in funding in 2026 to date.

Where does NeuroLex Diagnostics rank among its competitors?

NeuroLex Diagnostics ranks 7th amongst 12 active competitors, of which 4 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was LangAware, which secured $2.09M in Oct, 2023.

Who are the top competitors of NeuroLex Diagnostics?

NeuroLex Diagnostics' top competitors include CVAid, KeyWise AI and LangAware. Among them, LangAware secured the most recent funding round in October, 2023.

NeuroLex Diagnostics - 2026 Company Profile, Team, Funding & Competitors

NeuroLex Diagnostics is an acquired company based in Atlanta (United States), founded in 2016 by Drew Morris, James Fairey and Jim Schwoebel. It operates as a Voice AI platform delivering insights into mental, cognitive, respiratory health. NeuroLex Diagnostics has raised $210K in funding. The company has 12 active competitors, including 4 funded and 1 that has exited. Its top competitors include companies like CVAid, KeyWise AI and LangAware.

Company Details

Voice AI platform delivering insights into mental, cognitive, respiratory health. This innovative company unlocks the power of voice as a vital sign, providing continuous insights through its clinically validated vocal biomarker platform. By analyzing everyday conversations via voice-enabled apps and devices, the platform detects subtle changes in voice that can signal early health issues. This proactive approach enables timely actions and improved health outcomes. The company's API/SDK platform facilitates easy integration of vocal biomarker analysis into various health initiatives, offering early detection, risk stratification, increased engagement, and enhanced performance. The technology is built upon advanced machine learning and millions of medically-labeled voice samples, ensuring accurate and actionable health insights. This company is focused on preventative healthcare, empowering individuals and organizations to make informed decisions and manage health more effectively. This is a B2B SaaS platform.

Website: neurolex.ai
Social
Email ID: *****@neurolex.co
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Atlanta, United States

Stage

Acquired

Total Funding

$210K in 1 round

Latest Funding Round

Seed, Jun 2017, $*****

Investors

Betaworks

Ranked

7^th among 12 active competitors

Employee Count

2 as on Apr 30, 2026

Similar Companies

CVAid & 16 more

Exit Details

Acquired by Sonde Health (Aug 25, 2020)

View NeuroLex Diagnostics' full profile

NeuroLex Diagnostics got acquired by Sonde Health on Aug 25, 2020.

Click here to take a look at NeuroLex Diagnostics's acquisition in detail

NeuroLex Diagnostics has raised a total funding of $210K over 1 round. NeuroLex Diagnostics has 1 institutional investor.

Here is the list of recent funding rounds of NeuroLex Diagnostics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 2017	3377243	Seed	7808576	2285396	2629549	9194212

Access funding benchmarks and valuations. Sign up today!

View details of NeuroLex Diagnostics's funding rounds and investors

The founders of NeuroLex Diagnostics are Drew Morris, James Fairey and Jim Schwoebel.

Here are the details of NeuroLex Diagnostics' key team members:

Drew Morris: Co-Founder of NeuroLex Diagnostics.
James Fairey: Co-Founder of NeuroLex Diagnostics.
Jim Schwoebel: Co-Founder & CEO of NeuroLex Diagnostics.

View details of NeuroLex Diagnostics's Founder profiles and Board Members

NeuroLex Diagnostics' employee count trend

NeuroLex Diagnostics has 2 employees as of Apr 26. Here is NeuroLex Diagnostics's employee count trend over the years:

Employee count trend for NeuroLex Diagnostics

Uncover NeuroLex Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroLex Diagnostics include CVAid, KeyWise AI and LangAware. Here is the list of Top 10 competitors of NeuroLex Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CVAid 2018, Tel Aviv (Israel), Series A	Provider of system for early diagnosis of strokes	$4M	RAD BioMed, Philips & 1 others	40/100
2nd	KeyWise AI 2019, Chicago (United States), Funding Raised	Provider of AI-based software for the detection of brain disorder	-	Ginossar Ventures, Merus Capital & 4 others	36/100
3rd	LangAware 2019, Athens (Greece), Seed	AI-driven healthcare technology for detecting cognitive and mental health conditions using speech	$3.79M	Eleven, Metavallon & 1 others	36/100
4th	acceXible 2018, Barcelona (Spain), Seed	Provider of a cognitive disease diagnosis tool for healthcare professionals	$959K	EIT Health, Lanzadera	35/100
5th	Novoic 2019, London (United Kingdom), Seed	Developer of tools for the diagnosis of brain disease through speech	-	Anthemis Group, APEX Ventures & 12 others	33/100
6th	Peak Neurosciences 2015, Mumbai (India), Unfunded	Provider of device for cognitive health assessment	-	-	30/100
7th	NeuroLex Diagnostics 2016, Atlanta (United States), Acquired	Voice AI platform delivering insights into mental, cognitive, respiratory health	$210K	Betaworks	28/100
8th	Meet Astrid 2019, Lehi (United States), Unfunded	Provider of an AI assistant for autism	-	-	24/100
9th	PeakProfiling 2016, Berlin (Germany), Funding Raised	Algorithms to detect emotional states and physical conditions from the voice	-	InsurTech Hub Munich	23/100
10th	Grai 2017, Los Angeles (United States), Deadpooled	Voice analysis-based diagnostic apps	-	-	21/100